Clascoterone: Topical Antiandrogen for Acne

Overview / Definition Clascoterone (branded as Clascoterone cream 1%) is a topical antiandrogen agent recently approved for the treatment of acne vulgaris in patients aged 12 years and older. It acts primarily by blocking androgen receptors in the skin, thereby reducing the effects of androgens that contribute to acne pathogenesis. Epidemiology Acne vulgaris is one of the most prevalent skin conditions, affecting approximately 85% of adolescents and young adults at some point in their lives. The severity and persistence of acne can vary widely, with a significant portion of patients experiencing chronic symptoms into adulthood. The emergence of effective treatments like clascoterone is vital given the psychological and physical impacts of acne. Pathophysiology / Mechanism The pathophysiology of acne involves multiple factors, including: Increased sebum production: Stimulated by androgens, which are male hormones present in both men and women. Follicular hyperkeratinization: Leads to clogged pores, creating an environment conducive to bacterial growth. Inflammation: Mediated by the immune response to Propionibacterium acnes and other factors. Clascoterone functions by selectively antagonizing androgen receptors in the skin, thus: Reducing androgen-driven sebum production. Decreasing the inflammatory response in acne lesions. Helping to normalize keratinization within hair follicles. Clinical Presentation Patients with acne vulgaris present with: Open comedones: Blackheads Closed comedones: Whiteheads Inflammatory lesions: Papules, pustules, and nodules Potential scarring: Post-inflammatory hyperpigmentation or atrophic scars Acne can also have psychological impacts, leading to conditions such as anxiety and depression, particularly in cases of severe or persistent acne. Diagnosis / Workup The diagnosis of acne vulgaris is primarily clinical. Key components of the workup include: History taking: Assessing the onset, duration, and severity of acne, as well as any treat